Whalestream has ceased operations permanently
Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 12/18/2026 | CALL | $200.00 | 1,797 | +1,722 | +2,296.00% |
| 08/21/2026 | CALL | $150.00 | 22 | +18 | +450.00% |
| 12/18/2026 | CALL | $190.00 | 64 | +17 | +36.17% |
| 08/21/2026 | PUT | $120.00 | 13 | +9 | +225.00% |
| 09/18/2026 | CALL | $140.00 | 13 | +9 | +225.00% |
| 07/17/2026 | CALL | $160.00 | 266 | +7 | +2.70% |
| 12/18/2026 | PUT | $480.00 | 0 | 0 | |
| 12/18/2026 | PUT | $490.00 | 0 | 0 | |
| 12/18/2026 | CALL | $300.00 | 72 | -1 | -1.37% |
| 12/18/2026 | PUT | $130.00 | 127 | -1 | -0.78% |
| 07/17/2026 | CALL | $170.00 | 157 | -2 | -1.26% |
| 07/17/2026 | PUT | $135.00 | 51 | -2 | -3.77% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Amcap Fund | 3.29% | 2.29M | 653.75M |
| Smallcap World Fund | 3.25% | 2.27M | 646.95M |
| Vanguard Total Stock Market Index Fund | 3.03% | 2.11M | 602.47M |
| New Perspective Fund Inc | 2.60% | 1.81M | 516.54M |
| Vanguard Specialized-Health Care Fund | 2.47% | 1.72M | 491.17M |
| Fidelity Growth Company Fund | 2.46% | 1.72M | 490.1M |
| Vanguard Mid-Cap Index Fund | 2.32% | 1.62M | 461.72M |
| Growth Fund Of America Inc | 2.19% | 1.53M | 435.79M |
| Fidelity Select Portfolios - Medical Technology & Devices Port | 1.64% | 1.14M | 325.46M |
| Fidelity Select Portfolios - Health Care | 1.36% | 950k | 271.22M |
Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm
07/09 12:00 pm
GlobeNewswire Inc.
Read moreGDDY Investor News: If You Have Suffered Losses in GoDaddy Inc. (NYSE: GDDY), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
07/08 09:56 pm
GlobeNewswire Inc.
Read moreROSEN, GLOBAL INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODD
07/08 09:49 pm
GlobeNewswire Inc.
Read moreGainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Insulet Corporation (PODD)
07/06 10:49 am
GlobeNewswire Inc.
Read morePODD INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Insulet Corporation Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm
07/06 10:49 am
GlobeNewswire Inc.
Read moreVERI DEADLINE NOTICE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Veritone, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - VERI
07/05 07:37 pm
GlobeNewswire Inc.
Read moreROSEN, LEADING INVESTOR COUNSEL, Encourages Insulet Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – PODD
07/05 06:35 pm
GlobeNewswire Inc.
Read moreBronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm
07/03 03:08 pm
GlobeNewswire Inc.
Read moreFDA Flags High-Risk Recall Of Insulet's Omnipod 5 Pods Over Insulin Delivery Concerns
04/29 02:30 pm
Benzinga
Read moreINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GoHealth Inc. - GOCO
04/21 04:59 pm
GlobeNewswire Inc.
Read moreInsulet Stock Hits 52-Week Low - Here's Why
03/13 09:45 am
Benzinga
Read moreAccessible Health Platforms Gain Scale Across $6T Health and Wellness Market
02/13 12:26 pm
Benzinga
Read moreBVI Appoints Jim Hollingshead as President & Chief Executive Officer
01/19 10:00 am
GlobeNewswire Inc.
Read moreInsulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock
08/07 01:50 pm
Benzinga
Read moreInsulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5
08/07 01:08 pm
Benzinga
Read moreDiabetes Care Devices Market Size Projects USD 76.44 Billion by 2034
07/31 10:00 am
GlobeNewswire Inc.
Read more10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
06/28 09:10 am
The Motley Fool
Read moreGoldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
06/02 08:11 am
Benzinga
Read moreInsulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
05/14 02:53 pm
Investing.com
Read moreInsulin Pump Market Valuation to Jump to Reach US$ 25.40 Billion by 2033 | India and China Offering Lucrative Growth Opportunities Says Astute Analytica
12/24 10:30 am
GlobeNewswire Inc.
Read moreWearable Patch Market to Expand at a High 7.9% CAGR through 2031 | SkyQuest Technology
11/25 06:10 am
Benzinga
Read moreProPicks AI Top-10 Countdown: 2 Short-Term Power Plays Yielding Massive 40%+ Gains
10/28 04:35 am
Investing.com
Read moreShould You Continue to Retain PODD Stock in Your Portfolio Now?
09/04 02:30 pm
Benzinga
Read moreAffirm, Mongodb And Best Buy Are Among Top 10 Large Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
09/02 09:31 am
Benzinga
Read moreWhy Insulet Stock Was Zooming Higher This Week
08/30 07:20 am
The Motley Fool
Read moreThermo Fisher (TMO) Beats on Q2 Earnings, Raises 2024 EPS View - Zacks Investment Research
07/24 10:31 am
Zacks Investment Research
Read moreESLOY vs. PODD: Which Stock Is the Better Value Option?
06/25 11:40 am
Zacks Investment Research
Read moreInsulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
06/24 08:36 am
Zacks Investment Research
Read moreInsulet (PODD) Unveils Key Achievements for the Omnipod 5 System
06/21 08:33 am
Zacks Investment Research
Read moreWhere Insulet Stands With Analysts
05/30 08:00 am
Benzinga
Read moreHere's Why Insulet (PODD) is a Strong Momentum Stock
05/23 09:50 am
Zacks Investment Research
Read moreWhy Insulet (PODD) is a Top Growth Stock for the Long-Term
05/22 09:45 am
Zacks Investment Research
Read moreWall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
05/14 01:58 pm
Benzinga
Read moreInsulet (PODD) Q1 Earnings Top, 2024 Revenue View Raised
05/13 10:48 am
Zacks Investment Research
Read moreStocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? (CORRECTED)
05/10 01:28 pm
Benzinga
Read moreHere's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
05/09 05:30 pm
Zacks Investment Research
Read more4 Analysts Assess Insulet: What You Need To Know
05/07 09:00 am
Benzinga
Read moreAre You a Growth Investor? This 1 Stock Could Be the Perfect Pick
05/06 09:45 am
Zacks Investment Research
Read moreGear Up for Insulet (PODD) Q1 Earnings: Wall Street Estimates for Key Metrics
05/06 09:16 am
Zacks Investment Research
Read moreInsulet (PODD) Rises Higher Than Market: Key Facts
05/02 06:15 pm
Zacks Investment Research
Read moreWhy Insulet (PODD) is a Top Momentum Stock for the Long-Term
05/02 09:50 am
Zacks Investment Research
Read moreInsulet (PODD) Outperforms Broader Market: What You Need to Know
04/26 06:15 pm
Zacks Investment Research
Read moreHow to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
04/25 08:50 am
Zacks Investment Research
Read moreChemed (CHE) Lags Q1 Earnings Estimates, Reaffirms 2024 View
04/25 08:27 am
Zacks Investment Research
Read moreCharles River (CRL) to Report Q1 Earnings: Here's What to Expect
04/24 12:47 pm
Zacks Investment Research
Read moreBoston Scientific (BSX) Q1 Earnings Beat Estimates, View Raised
04/24 12:40 pm
Zacks Investment Research
Read moreInsulet (PODD) Awaits Q1 Earnings Release: Here's What to Expect
04/24 08:42 am
Zacks Investment Research
Read more